Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Foppoli

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Recenti Progressi in Medicina|December 9, 2010
[Treatment of primary central nervous system lymphoma: recent advances]Marco Foppoli, Andrés J M Ferreri
Cancer Chemotherapy and Pharmacology|June 13, 2021
A minimal physiologically based pharmacokinetic model for high-dose methotrexateGiuseppe Pesenti, Marco Foppoli, Davide Manca
European Journal of Haematology|August 27, 2014
Gamma-delta t-cell lymphomasMarco Foppoli, Andrés J M Ferreri
Recenti Progressi in Medicina|December 22, 2012
[Cardiac involvement by non-Hodgkin's lymphoma in an HIV-positive patient with hypertrophic obstructive cardiomyopathy]Barbara Demarchi, Marco Foppoli, Rachele Contri, et al.
Cancer Letters|November 13, 2007
Primary central nervous system lymphomas: salvage treatment after failure to high-dose methotrexateMichele Reni, Elena Mazza, Marco Foppoli, et al.
Recenti Progressi in Medicina|June 11, 2013
[The primary mediastinal lymphoma: state of the art and therapeutical perspectives]Marco Foppoli, Giovanni Citterio, Giovanni Donadoni, et al.
Expert Opinion on Therapeutic Targets|October 4, 2021
Implications of recent molecular achievements in early diagnosis and precision treatments for primary CNS lymphomaTeresa Calimeri, Sara Steffanoni, Marco Foppoli, et al.
Frontiers in Immunology|February 25, 2017
Interleukin-1 Receptor Blockade Rescues Myocarditis-Associated End-Stage Heart FailureGiulio Cavalli, Marco Foppoli, Luca Cabrini, et al.
Texas Heart Institute Journal|December 15, 2015
Primary Cardiac Lymphoma in an Immunocompetent 71-Year-Old ManClaudia Montanaro, Ferdinando Loiacono, Gabriele Fragasso, et al.
Nature Clinical Practice. Oncology|August 30, 2008
The impact of histopathologic diagnosis on the proper management of testis neoplasmsGiovanni Ponti, Maurilio Ponzoni, Andrés Jm Ferreri, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Recenti Progressi in Medicina|December 9, 2010
[Treatment of primary central nervous system lymphoma: recent advances]Marco Foppoli, Andrés J M Ferreri
Cancer Chemotherapy and Pharmacology|June 13, 2021
A minimal physiologically based pharmacokinetic model for high-dose methotrexateGiuseppe Pesenti, Marco Foppoli, Davide Manca
European Journal of Haematology|August 27, 2014
Gamma-delta t-cell lymphomasMarco Foppoli, Andrés J M Ferreri
Recenti Progressi in Medicina|December 22, 2012
[Cardiac involvement by non-Hodgkin's lymphoma in an HIV-positive patient with hypertrophic obstructive cardiomyopathy]Barbara Demarchi, Marco Foppoli, Rachele Contri, et al.
Cancer Letters|November 13, 2007
Primary central nervous system lymphomas: salvage treatment after failure to high-dose methotrexateMichele Reni, Elena Mazza, Marco Foppoli, et al.
Recenti Progressi in Medicina|June 11, 2013
[The primary mediastinal lymphoma: state of the art and therapeutical perspectives]Marco Foppoli, Giovanni Citterio, Giovanni Donadoni, et al.
Expert Opinion on Therapeutic Targets|October 4, 2021
Implications of recent molecular achievements in early diagnosis and precision treatments for primary CNS lymphomaTeresa Calimeri, Sara Steffanoni, Marco Foppoli, et al.
Frontiers in Immunology|February 25, 2017
Interleukin-1 Receptor Blockade Rescues Myocarditis-Associated End-Stage Heart FailureGiulio Cavalli, Marco Foppoli, Luca Cabrini, et al.
Texas Heart Institute Journal|December 15, 2015
Primary Cardiac Lymphoma in an Immunocompetent 71-Year-Old ManClaudia Montanaro, Ferdinando Loiacono, Gabriele Fragasso, et al.
Nature Clinical Practice. Oncology|August 30, 2008
The impact of histopathologic diagnosis on the proper management of testis neoplasmsGiovanni Ponti, Maurilio Ponzoni, Andrés Jm Ferreri, et al.
Pageof 3